Avazzia-University of Texas Southwestern Medical Center-Tennant Biomodulator® PRO Perfusion Study

计划入组 6 人 · 首次发布于 2019 年 2 月 18 日

The Memorial Sloan-Kettering Cancer Center (MSKCC

计划入组 3,194 人 · 首次发布于 2012 年 1 月 13 日

Sí Texas Hope Family Health Center

计划入组 585 人 · 首次发布于 2019 年 4 月 16 日

AAV9-based gene replacement therapy (University of Texas Southwestern Medical Center)

RFT5-dgA Immunotoxin（The University Of Texas Southwestern Medical Center）

Tat-beclin-1

MEMORIAL HERMANN HEALTH SYSTEM

United States

Memorial Hermann Healthcare System

United States

White Memorial Medical Center

United States

Johnson & Johnson Submits OTTAVA Robotic Surgical System to FDA for De Novo Classification

Johnson & Johnson Completes First Surgeries with OTTAVA Robotic System in Clinical Trial

Texas Cardiac Arrhythmia Institute First in US to Use FDA-Approved Dual-Energy Ablation Catheter